BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23692699)

  • 1. Recurrence patterns and management of oral cavity premalignant lesions.
    Arnaoutakis D; Bishop J; Westra W; Califano JA
    Oral Oncol; 2013 Aug; 49(8):814-7. PubMed ID: 23692699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic.
    Ho MW; Field EA; Field JK; Risk JM; Rajlawat BP; Rogers SN; Steele JC; Triantafyllou A; Woolgar JA; Lowe D; Shaw RJ
    Br J Oral Maxillofac Surg; 2013 Oct; 51(7):594-9. PubMed ID: 23601832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting carbon dioxide laser treatment for oral precancer: a patient cohort study.
    Hamadah O; Thomson PJ
    Lasers Surg Med; 2009 Jan; 41(1):17-25. PubMed ID: 19143013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of ablation of anal high-grade squamous intraepithelial lesions: recurrence and incidence of cancer.
    Goldstone SE; Johnstone AA; Moshier EL
    Dis Colon Rectum; 2014 Mar; 57(3):316-23. PubMed ID: 24509453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment outcome of oral premalignant lesions.
    Holmstrup P; Vedtofte P; Reibel J; Stoltze K
    Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up results of Nd: YAG laser treatment of premalignant and malignant (Stage I) squamous cell carcinoma of the oral cavity.
    Tewari M; Rai P; Singh GB; Kumar M; Shukla HS
    J Surg Oncol; 2007 Mar; 95(4):281-5. PubMed ID: 17326123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical oral cavity chemoprophylaxis using isotretinoin rinse: A 15-year experience.
    Kadakia S; Badhey A; Milam M; Lee T; Ducic Y
    Laryngoscope; 2017 Jul; 127(7):1595-1599. PubMed ID: 28000225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
    Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
    J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of oral carcinoma: benefits of early precancerous intervention.
    Goodson ML; Thomson PJ
    Br J Oral Maxillofac Surg; 2011 Mar; 49(2):88-91. PubMed ID: 20678830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management.
    Thomson PJ; Wylie J
    Int J Oral Maxillofac Surg; 2002 Apr; 31(2):145-53. PubMed ID: 12102411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management for premalignant lesions of the oral cavity.
    Panwar A; Lindau R; Wieland A
    Expert Rev Anticancer Ther; 2014 Mar; 14(3):349-57. PubMed ID: 24559323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up.
    Arduino PG; Surace A; Carbone M; Elia A; Massolini G; Gandolfo S; Broccoletti R
    J Oral Pathol Med; 2009 Jul; 38(6):540-4. PubMed ID: 19453839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of infrared coagulator ablation of anal high-grade dysplasia in men who have sex with men.
    Goldstone RN; Goldstone AB; Russ J; Goldstone SE
    Dis Colon Rectum; 2011 Oct; 54(10):1284-92. PubMed ID: 21904144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of excision of oral erythroplakia.
    Yang SW; Lee YS; Chang LC; Hsieh TY; Chen TA
    Br J Oral Maxillofac Surg; 2015 Feb; 53(2):142-7. PubMed ID: 25467247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting recurrence after oral precancer treatment: use of cell cycle analysis.
    Thomson PJ; Hamadah O; Goodson ML; Cragg N; Booth C
    Br J Oral Maxillofac Surg; 2008 Jul; 46(5):370-5. PubMed ID: 18282643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma.
    Jerjes W; Upile T; Hamdoon Z; Mosse CA; Akram S; Hopper C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):180-7. PubMed ID: 21232996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
    DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
    Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of different surgical margin conditions on local recurrence of oral squamous cell carcinoma.
    Kurita H; Nakanishi Y; Nishizawa R; Xiao T; Kamata T; Koike T; Kobayashi H
    Oral Oncol; 2010 Nov; 46(11):814-7. PubMed ID: 20920879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of oral squamous cell carcinoma treated with inadequate excisional biopsy.
    Bailey JS; Blanchaert RH; Ord RA
    J Oral Maxillofac Surg; 2001 Sep; 59(9):1007-10; discussion 1011. PubMed ID: 11526566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.
    Hsue SS; Wang WC; Chen CH; Lin CC; Chen YK; Lin LM
    J Oral Pathol Med; 2007 Jan; 36(1):25-9. PubMed ID: 17181738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.